Filing Details
- Accession Number:
- 0001209191-21-071650
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-30 21:00:16
- Reporting Period:
- 2021-12-28
- Accepted Time:
- 2021-12-30 21:00:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Therapeutics Public Ltd Co | HZNP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611468 | W. Paul Hoelscher | C/O Horizon Therapeutics Plc, 70 Saint Stephen?S Green Dublin L2 D02 E2X4 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2021-08-25 | 6,163 | $0.00 | 2,098 | No | 4 | G | Direct | |
| Ordinary Shares | Acquisiton | 2021-08-25 | 6,163 | $0.00 | 178,389 | No | 4 | G | Indirect | By Trust |
| Ordinary Shares | Disposition | 2021-12-03 | 1,049 | $0.00 | 1,049 | No | 4 | G | Direct | |
| Ordinary Shares | Acquisiton | 2021-12-28 | 8,575 | $15.96 | 9,624 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-12-28 | 8,575 | $110.00 | 1,049 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | G | Indirect | By Trust |
| No | 4 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-12-28 | 8,575 | $0.00 | 8,575 | $15.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 56,365 | 2024-06-26 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2021.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
